4 results
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Authorisation status
Authorised Remove Authorised filter
Patient safety
Yes Remove Yes filter
-
List item
Human medicine European public assessment report (EPAR): Gilenya
fingolimod hydrochloride , Multiple Sclerosis
Date of authorisation: 17/03/2011,,
, Revision: 28, Authorised, Last updated: 04/02/2021
-
List item
Human medicine European public assessment report (EPAR): Xarelto
rivaroxaban, Arthroplasty, Replacement, Venous Thromboembolism
Date of authorisation: 30/09/2008,,
, Revision: 33, Authorised, Last updated: 02/02/2021
-
List item
Human medicine European public assessment report (EPAR): Xeljanz
tofacitinib citrate, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017,
Date of refusal: 25/04/2013,,
, Revision: 16, Authorised, Last updated: 28/01/2021
-
List item
Human medicine European public assessment report (EPAR): Lemtrada
alemtuzumab, Multiple Sclerosis
Date of authorisation: 12/09/2013,,
, Revision: 10, Authorised, Last updated: 21/07/2020